Results 261 to 270 of about 314,420 (315)
Indeterminate Phase/Grey Zone of Chronic Hepatitis B: Clinical Features, Outcomes and Molecular Insights. [PDF]
Franzè MS +5 more
europepmc +1 more source
This nationwide registry‐based study describes the clinical and molecular characteristics of 78 patients with transfusion‐dependent beta‐thalassemia in Spain. Comprehensive genetic analysis revealed marked molecular heterogeneity, with 24 HBB mutations identified and a predominance of β0 genotypes, alongside generally effective transfusion and iron ...
Ana Villegas +41 more
wiley +1 more source
Efficacy and safety of tenofovir amibufenamide in patients with chronic hepatitis B: a real-world clinical study. [PDF]
Fan R, Fan H, Tan L, Zhang J, Ai L.
europepmc +1 more source
In nonspecialist departments, most anti‐HCV–positive individuals do not proceed to RNA testing. The Elecsys HCV Duo assay simultaneously detects anti‐HCV antibodies and core antigen from a single blood draw and preferentially identifies patients with clinically meaningful viral loads.
Hiroko Setoyama +23 more
wiley +1 more source
Diagnostic Accuracy of Prognostic Nutritional Index and Systemic Immune-Inflammatory Index in Predicting Fibrosis and Histological Activity in Chronic Hepatitis B. [PDF]
Uguz AC, Bayram M, Uzun H, Tabak O.
europepmc +1 more source
Refining surveillance of hepatocellular carcinoma in chronic hepatitis B through biomarker-based risk stratification. [PDF]
Tseng TC, Huang SC, Kao JH.
europepmc +1 more source
Efficacy of pegylated interferon alpha in treating postpartum women with chronic hepatitis B virus infection: a multicenter prospective study. [PDF]
Gong H +10 more
europepmc +1 more source

